Private Capital Group’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $62K | Sell |
126
-1
| -0.8% | -$492 | 0.05% | 402 |
|
|
2022
Q1 | $72K | Sell |
127
-24
| -16% | -$13.6K | 0.02% | 513 |
|
|
2021
Q4 | $114K | Hold |
151
| – | – | 0.02% | 383 |
|
|
2021
Q3 | $113K | Buy |
151
+2
| +1% | +$1.5K | 0.03% | 389 |
|
|
2021
Q2 | $96K | Buy |
149
+8
| +6% | +$5.15K | 0.02% | 425 |
|
|
2021
Q1 | $81K | Sell |
141
-259
| -65% | -$149K | 0.02% | 458 |
|
|
2020
Q4 | $233K | Buy |
400
+33
| +9% | +$19.2K | 0.04% | 272 |
|
|
2020
Q3 | $189K | Sell |
367
-45
| -11% | -$23.2K | 0.04% | 293 |
|
|
2020
Q2 | $186K | Sell |
412
-26
| -6% | -$11.7K | 0.04% | 296 |
|
|
2020
Q1 | $154K | Buy |
438
+18
| +4% | +$6.33K | 0.04% | 298 |
|
|
2019
Q4 | $155K | Buy |
420
+28
| +7% | +$10.3K | 0.03% | 327 |
|
|
2019
Q3 | $130K | Buy |
392
+370
| +1,682% | +$123K | 0.02% | 398 |
|
|
2019
Q2 | $6K | Sell |
22
-368
| -94% | -$100K | ﹤0.01% | 1574 |
|
|
2019
Q1 | $119K | Buy |
390
+280
| +255% | +$85.4K | 0.02% | 405 |
|
|
2018
Q4 | $26K | Buy |
110
+39
| +55% | +$9.22K | 0.01% | 975 |
|
|
2018
Q3 | $22K | Buy |
71
+49
| +223% | +$15.2K | ﹤0.01% | 1099 |
|
|
2018
Q2 | $6K | Buy |
22
+2
| +10% | +$545 | ﹤0.01% | 1593 |
|
|
2018
Q1 | $5K | Buy |
20
+8
| +67% | +$2K | ﹤0.01% | 1580 |
|
|
2017
Q4 | $3 | Buy |
+12
| New | +$3 | ﹤0.01% | 1748 |
|